MEDLINE 8. Borger MA, Ivanov J, Armstrong S, Christie-Hrybinski D, Feindel CM, David TE: Twenty-year result of the Hancock II bioprosthesis. J Heart Valve Dis 2006; 15: 49–55. MEDLINE 9.
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as warfarin, although this strategy might come at a higher cost of bleeding, ...
"The ENBALV trial provides the first large-scale evidence on the use of direct oral anticoagulants in low-risk patients early after bioprosthetic valve surgery," said lead investigator Chisato ...
A new study indicates that use of bioprosthetic plugs in the surgical treatment of complex anal fistulas is associated with a long-term success rate of 81%. The main focus of surgical treatment of ...
formation on the valve. Patients who receive a bioprosthetic (made with human or animal tissue) heart valve typically need anticoagulants for three to six months after surgery. The standard ...
C. Michael Gibson speaks with Raj Makkar about PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves Receive the the latest ...